عربي English Türkçe اردو فارسى
Logo
Latest News
Business

Protection of Intellectual Property Helps Saudi Pharmaceutical Industry Attract More Investments

Approving protection of intellectual property prompts an increase in investments in the Saudi pharmaceutical industry. (Asharq Al-Awsat)
Approving protection of intellectual property prompts an increase in investments in the Saudi pharmaceutical industry. (Asharq Al-Awsat)
TT
TT

Protection of Intellectual Property Helps Saudi Pharmaceutical Industry Attract More Investments

Approving protection of intellectual property prompts an increase in investments in the Saudi pharmaceutical industry. (Asharq Al-Awsat)
Approving protection of intellectual property prompts an increase in investments in the Saudi pharmaceutical industry. (Asharq Al-Awsat)

Samir Khalil, executive director for the Pharmaceutical Research and Manufacturers of America (PhRMA) Middle East and Africa (MEA), confirmed that Saudi Arabia’s protection of intellectual property will boost the Kingdom’s pharmaceutical industry.

Khalil also predicted that the size of the Saudi pharmaceutical market, which is the largest in the region, will reach 39 billion riyals ($10.4 billion) by 2024.

Through empowering the Saudi Authority for Intellectual Property, the Kingdom’s leadership aims to encourage pharmaceutical manufacture, Khalil said in an interview with Asharq Al-Awsat.

He noted that PhRMA and its affiliated companies view positively the Saudi plan for national transformation, known as Vision 2030, especially on how it tackles developing the innovative pharmaceutical sector through attracting more investment and conducting advanced clinical research.

More so, the Global Intellectual Property Challenges Forum, held on the sidelines of the 2020 G20 Riyadh summit under Saudi Presidency, has strengthened existing policies and global cooperation on developing and manufacturing treatments and vaccines for the coronavirus.

Khalil indicated that there are 570 treatments and 51 vaccines for Covid-19 currently being tested in the world.

He stressed that the Middle East and Africa region hosts one of the world’s most dynamic pharmaceutical markets with an accelerating industrial growth.

Noting that Saudi Arabia is one of the largest pharmaceutical markets in the region, Khalil said that the Kingdom has witnessed dramatic development over the past years. This was triggered by the increase in population, the rise in GDP and the emergence of more diseases that require treatment.

Speaking on Vision 2030’s strategy for encouraging investment in the pharmaceutical industry, Khalil said: “We have worked over the past years to explore many opportunities to promote policies that contribute to attracting innovation to the region.”

PhRMA's goals focus on helping patients by providing them with the latest innovative medicines and vaccines. The trade group also places great importance on strengthening the concept of protecting intellectual property in the pharmaceutical industry sector. Systems that provide an incubating environment for the protection of innovation are perceived as inviting.

Most Viewed

 
 
Business

Saudi Non-Oil Exports Hit Two-Year High

The King Abdulaziz Port in Dammam, eastern Saudi Arabia. (“Mawani” port authority)
The King Abdulaziz Port in Dammam, eastern Saudi Arabia. (“Mawani” port authority)
TT
TT

Saudi Non-Oil Exports Hit Two-Year High

The King Abdulaziz Port in Dammam, eastern Saudi Arabia. (“Mawani” port authority)
The King Abdulaziz Port in Dammam, eastern Saudi Arabia. (“Mawani” port authority)

Saudi Arabia’s non-oil exports soared to a two-year high in May, reaching SAR 28.89 billion (USD 7.70 billion), marking an 8.2% year-on-year increase compared to May 2023.

On a monthly basis, non-oil exports surged by 26.93% from April.

This growth contributed to Saudi Arabia’s trade surplus, which recorded a year-on-year increase of 12.8%, reaching SAR 34.5 billion (USD 9.1 billion) in May, following 18 months of decline.

The enhancement of the non-oil private sector remains a key focus for Saudi Arabia as it continues its efforts to diversify its economy and reduce reliance on oil revenues.

In 2023, non-oil activities in Saudi Arabia contributed 50% to the country’s real GDP, the highest level ever recorded, according to the Ministry of Economy and Planning’s analysis of data from the General Authority for Statistics.

Saudi Finance Minister Mohammed Al-Jadaan emphasized at the “Future Investment Initiative” in October that the Kingdom is now prioritizing the development of the non-oil sector over GDP figures, in line with its Vision 2030 economic diversification plan.

A report by Moody’s highlighted Saudi Arabia’s extensive efforts to transform its economic structure, reduce dependency on oil, and boost non-oil sectors such as industry, tourism, and real estate.

The Saudi General Authority for Statistics’ monthly report on international trade noted a 5.8% growth in merchandise exports in May compared to the same period last year, driven by a 4.9% increase in oil exports, which totaled SAR 75.9 billion in May 2024.

The change reflects movements in global oil prices, while production levels remained steady at under 9 million barrels per day since the OPEC+ alliance began a voluntary reduction in crude supply to maintain prices. Production is set to gradually increase starting in early October.

On a monthly basis, merchandise exports rose by 3.3% from April to May, supported by a 26.9% increase in non-oil exports. This rise was bolstered by a surge in re-exports, which reached SAR 10.2 billion, the highest level for this category since 2017.

The share of oil exports in total exports declined to 72.4% in May from 73% in the same month last year.

Moreover, the value of re-exported goods increased by 33.9% during the same period.